Freeman updates powder analysis tech
Freeman Technology has added a new “intuitive” control system to its multi-purpose powder analysis system.
Freeman Technology has added a new “intuitive” control system to its multi-purpose powder analysis system.
A risk-benefit assessment framework for new drugs is a must for Pharmas, a leading industry expert told attendees at BIO 2012 in Boston.
Boehringer Ingelheim has rebranded its contract development and manufacturing business as BioXcellence.
AMRI is considering further cuts to its US operations as it prepares for the loss of Allegra revenues in 2015.
Outsourcing-Pharma.com presents a roundup of eClinical news, including developments at Parexel, Datatrak, and MedNet.
Indonesia and the Philippines have been earmarked as the next hot emerging pharmaceutical outsourcing markets in a new study.
New 'similar biologics' guidelines will curb the rising cost of innovation, attract overseas investment and ensure patients have access to drugs according to the Indian Government team which launched them at BIO 2012.